Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis
Journal of Pharmacy and Pharmacology · 2023
DOI: 10.1093/jpp/rgad008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Yan Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Radiotherapy, Hubei Provincial Cancer Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Melitten, Colorectal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
The primary goal of the current study was to investigate the effect of melittin on colorectal cancer (CRC).
Methods
The viability of cancer cells was tested using the MTT assay, and the apoptosis of tumour cells was assayed using Annexin V/PI staining in vitro or TUNEL staining in vivo. The in vivo toxicity and efficacy of melittin were assessed in a xenograft mouse model.
Results
Melittin inhibited the viability of CRC cell lines and induced apoptosis in SW480 cells by regulating apoptosis-related proteins. Melittin triggered endoplasmic reticulum (ER) stress and caused an imbalance in calcium homeostasis in SW480 cells. An absence of melittin triggered ER stress via the calcium chelating agent BAPTA/AM, and the IP3R inhibitor 2-aminoethoxydiphenyl borate (2-APB) impaired melittin-induced apoptosis in SW480 cells. Melittin treatment suppressed tumour growth but did not affect the body weight of SW480 tumour-bearing mice. Unlike cisplatin and 5-fluorouracil, melittin treatment did not change the biochemical and haematological parameters of the tumour-bearing mice. Finally, in these mice, melittin treatment induced ER stress, which was then blocked by BAPTA/AM, whilst 2-APB impaired the growth inhibitory effect of melittin.
Conclusion
Melittin treatment inhibits CRC progression by inducing ER stress and an imbalance in calcium homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Abdominal Radiotherapy, Hubei Provincial Cancer Hospital, Wuhan, China.
- Colorectal Cancer Clinical Medical Research Center of Hubei Province, Wuhan, China.
- Colorectal Cancer Clinical Medical Research Center of Wuhan, China.
Zitieren
APA
Luo, Y., Xu, C. M., Luo, B., Liang, G., & Zhang, Q. (2023). Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad008
Vancouver
Luo Y, Xu CM, Luo B, Liang G, Zhang Q. Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad008
BibTeX
@article{Luo2023,
author = {Luo, Yan and Xu, Chong-Ming and Luo, Bo and Liang, Gai and Zhang, Qu},
title = {Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
doi = {10.1093/jpp/rgad008}
}
EUVIMED